Protocol for PI3K inhibitor-free differentiation and maturation of human iPSC-derived arterial- and venous-like endothelial cells
Vascular malformations caused by genetic PI3K pathway activation are highly debilitating and hard to treat. Here, we present a PI3K inhibitor-free protocol to differentiate arterial and venous endothelial cells from human induced pluripotent stem cells (iPSCs) in 2D and 3D formats. We describe steps for iPSC culture, cell seeding on a synthetic matrix, defined media preparation, magnetic-activated cell sorting, and endothelial cell maturation under shear stress. We then detail procedures for determining cell density and culture duration for robust functional phenotyping.
Authors
- Ralitsa Radostinova Madsen (ORCID: https://orcid.org/0000-0001-8844-5167)
- Oliwia N Mruk (ORCID: https://orcid.org/0009-0000-6516-3757)
- Alexandra J. Musk
Institutions
- University of Dundee (GB)
- MRC Protein Phosphorylation and Ubiquitylation Unit (GB)
Publication Details
- Journal
- STAR Protocols
- Published
- 2026-07-30
- DOI
- https://doi.org/10.1016/j.xpro.2026.104668
- Primary Topic
- Angiogenesis and VEGF in Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Wellcome Trust
- UK Research and Innovation
- Medical Research Council